---
title: Wells Fargo、沃尔玛与Atai生命科学：股市焦点股解析
summary: 本报告聚焦Wells Fargo盈利指标提升、Walmart与OpenAI合作以及Atai生命科学因精神健康药物前景而大涨等股市热点，分析了这些公司股价异动背后的驱动因素。
area: tech-insights
category: technology
project:
- ai-impact-analysis
- investment-strategy
- market-cycles
tags:
- earning-season
- stock-movers
people: []
companies_orgs:
- atai-life-sciences
- walmart
- wells-fargo
products_models: []
media_books:
- bloomberg-podcasts
date: '2025-10-15'
author: Bloomberg Podcasts
speaker: Bloomberg Podcasts
draft: true
guest: ''
insight: ''
layout: post.njk
series: ''
source: https://www.youtube.com/watch?v=f83uXtAdlV4
status: evergreen
---
### 市场概览与银行股表现

Carol Master: 我是Carol Master，Isabelle Lee也在场。让我们来看看今天股市中的活跃股票。彭博新闻股票记者Natalyia Kiny Javich也在演播室，我们将谈谈大银行的表现。

Carol Master: I'm Carol Master along with Isabelle Lee. Let's get to some stocks on the move. Bloomberg News equities reporter Natalyia Kiny Javich is here in studio and we've got to talk about the big banks.

Natalyia Kiny Javich: 它们确实表现活跃，有涨有跌。是的，这是一个有趣的财报季。我们先从**富国银行** (Wells Fargo: 一家美国跨国金融服务公司) 开始，股票代码是WFC。它是**标普500** (S&P 500: 美国500家市值最大上市公司股票指数) 中表现最好的股票，上涨了7%。

Natalyia Kiny Javich: They were definitely moving. Some good, some bad. Yes, it is an interesting earning season. So, let's start with Wells Fargo. The ticker is WFC. This is the best performer in the S&P 500. The stock is up by 7%.

Natalyia Kiny Javich: 当然，这发生在银行上调其关键盈利能力指标——**有形普通股股本回报率** (Return on Tangible Common Equity, ROTCE: 衡量银行盈利能力的关键指标) 目标至17%到18%（此前为15%）之后。

Natalyia Kiny Javich: Of course, this came after the bank raised its key profitability metric known as target for return on tangible common equity to a range between 17 to 18% from a previous level of 15.

Natalyia Kiny Javich: 当然，这发生在**美联储** (Federal Reserve: 美国中央银行) 于6月取消了**资产上限** (Asset Cap: 限制银行资产规模的监管措施) 之后，因为我们知道富国银行曾被限制扩大其资产规模。所以现在这是一个重大的发展。

Natalyia Kiny Javich: Of course, it came after the Federal Reserve removed an asset cap in June because we know that Wells Fargo was restricted from expanding the size of its asset size. So now it is a big development.

Natalyia Kiny Javich: 然而，就盈利本身而言，我们看到**净利息收入** (Net Interest Income, NII: 银行核心盈利指标，利息收入减去利息支出) 低于预期，而**每股收益** (EPS: Earnings Per Share, 衡量公司盈利能力的指标) 和**收入** (Revenue: 公司销售商品或提供服务所得的总金额) 则符合预期。

Natalyia Kiny Javich: However, on the earning side itself, we saw that net interest income came below expectations. EPS and revenue were in line.

Natalyia Kiny Javich: 我们关注的另一家大银行当然是**摩根大通** (J.P. Morgan: 一家全球领先的金融服务公司)，股票代码是JPM。该股收盘下跌了近2%。

Natalyia Kiny Javich: And then another big bank we are watching is of course JP Morgan. The ticker is JPM. The stock finished the trading session down by almost 2%.

Natalyia Kiny Javich: 有几个亮点。我们看到收入是由**投资银行费用** (Investment Banking Fees: 投资银行通过承销、并购咨询等业务收取的费用) 驱动的。对我来说，这特别有趣，因为我也关注**首次公开募股市场** (IPO market: 公司首次向公众出售股票的市场)。我们看到了一些复苏，但首席执行官杰米·戴蒙强调了经济和劳动力市场的疲软。

Natalyia Kiny Javich: Couple highlights. Of course, we saw that the revenue was driven by investment banking fees. For me, it's specifically interesting because I cover the IPO market as well. We saw a recovery, but of course, highlights from CEO Jamie Diamond about softness in the economy, labor market.

Carol Master: 真是太棒了。如果你不知道我们在谈论谁，只需访问Bloomberg.com查看相关报道。

Carol Master: Got to love it. If you don't know who we're talking about, just check out the story at Bloomberg.com.

### 沃尔玛与人工智能的结合

Carol Master: 沃尔玛怎么样？这也是一个非常大的美国故事。

Carol Master: What about Walmart? This is also a really big American.

Natalyia Kiny Javich: 这确实是一个大新闻。就在昨天，我们还在讨论还有谁想与**OpenAI** (一家人工智能研究和部署公司) 合作，而现在，沃尔玛来了。

Natalyia Kiny Javich: It is a big story. Just yesterday, we spoke, who else want to collaborate with OpenAI? And here we are.

Natalyia Kiny Javich: 沃尔玛的股票代码是WMT，股价上涨了近5%。这当然是公司宣布将与OpenAI合作，让购物者能够在**ChatGPT** (基于OpenAI大型语言模型的聊天机器人) 上浏览和购买产品之后。

Natalyia Kiny Javich: We have Walmart. The ticker is WMT. The stock is up by almost 5%. And of course, it came after announcement that the company will team up with OpenAI and enable shoppers to browse and buy products on ChatGPT.

Natalyia Kiny Javich: 这无疑是一大推动。分析师们对此感到非常兴奋，他们看到了“重大机遇”。具体来说，**瑞银集团** (UBS: 瑞士的一家全球性金融服务公司) 和**D.A. Davidson** (一家美国投资银行和财富管理公司) 的分析师们表示，这实际上使沃尔玛成为所有传统零售商中的赢家。

Natalyia Kiny Javich: And of course, it is a kind of big push. Analysts are pretty excited about that. They see "significant opportunities." Specifically, UBS analysts are saying that and D.A. Davidson, excuse me, analysts is saying that it is actually making the case for Walmart to be a winner among all traditional retailers in this kind of situation.

Carol Master: 这难道不引人深思吗？接下来会是谁？我们现在是不是会突然从每个人那里得到大量的购买按钮？我不知道。

Carol Master: Doesn't it beg the question, who's next? Do we now all of a sudden get a ton of buy buttons from everybody? I don't know.

Natalyia Kiny Javich: 是的，你说得对。这确实是我没有预料到的事情。但如果你仔细想想，这确实有道理。当然，你希望有一个人工智能来帮助你处理购物清单。早些时候来自电视的Matt提到，他甚至用ChatGPT来查找菜谱。

Natalyia Kiny Javich: Yes, you're right. This is something I didn't see coming actually. But if you think about it, it kind of makes sense. Of course, you want to have AI to help you with whatever your shopping list is. And Matt earlier from TV made the case that he even uses ChatGPT for recipes.

Carol Master: 他确实用它。是的，他完全是这样。Tim也做同样的事情。他会说：“我的冰箱里有什么什么东西，等等，我能用它们做什么？”我喜欢它。我喜欢玩它。我工作时也用过一点，这很有趣。

Carol Master: He uses it for it. Yeah, he totally does. Tim does the same thing. He'll be like, "Here's what's in my fridge or something and so on and so forth. What can I do with it?" I love it. I love playing with it. I've used it a little bit for work and stuff, but it's kind of fun.

### Atai生命科学的异动

Carol Master: 好的，有一家公司我不太熟悉，但它今天确实很活跃。

Carol Master: All right. There's a company I'm not familiar with, but it definitely was on the move today.

Natalyia Kiny Javich: 是的，这是一个有趣的故事。这家公司叫**Atai生命科学** (Atai Life Sciences: 一家临床阶段的生物制药公司)，股票代码是ATI。该股今天上涨了11%。

Natalyia Kiny Javich: Yes, it is an interesting story. The company is called Atai Life Sciences. The ticker is ATI. The stock jumped by 11% today.

Natalyia Kiny Javich: 这是一家**临床试验阶段生物制药公司** (Clinical Trial Stage Biopharmaceutical Company: 正在进行药物人体试验的制药公司)。它今天在制药领域，以及其他**迷幻药股票** (Psychedelic Stocks: 专注于开发迷幻剂作为治疗药物的公司的股票) 中，是涨幅最大的股票之一。

Natalyia Kiny Javich: This is a clinical trial stage biopharmaceutical company. It was among the biggest movers today in the pharmaceutical space across other psychedelic stocks.

Natalyia Kiny Javich: 这一上涨发生在一个共和党州参议员在北卡罗来纳州表示，该州可以在扩大退伍军人获得精神健康药物方面“引领全国”之后，因为这家公司专门开发精神疾病的治疗方法。

Natalyia Kiny Javich: So it came after a Republican state senator in North Carolina said that the state could "lead the nation" in expanding military veterans' access to mental health drugs because this company specifically develops treatments for mental health diseases.

Natalyia Kiny Javich: 这是根据一份名为《**大麻时刻**》(Marijuana Moment: 一家专注于大麻新闻和政策的出版物) 的出版物的报道。所以我们确实看到这些股票今天都在上涨。

Natalyia Kiny Javich: This is according to a report from a publication called Marijuana Moment. So we do see that these stocks are on the move today.

Carol Master: 是的。Nem机构启动了对该公司的覆盖，并给予“买入”评级，目标价为12美元。

Carol Master: Yeah. And Nem initiated coverage of the company with a recommendation of buy and a price target of $12.

Natalyia Kiny Javich: 是的，不是一家公司。

Natalyia Kiny Javich: Yeah. Not a company.

Carol Master: 几乎是今天收盘价的两倍。顺便说一下，该股收于6美元。今年上涨了351%。这太疯狂了吧？

Carol Master: Almost doubling today's price. By the way, the stock finished at six. 351% higher this year. Is that crazy?

Natalyia Kiny Javich: 我觉得这些公司，我们可能会忘记它们，然后当一个重大公告出现时，它们就会突然爆发。

Natalyia Kiny Javich: I feel like these companies they can we forget about them and then when a big announcement comes, bam.